DrugPatentWatch Database Preview
« Back to Dashboard
The generic ingredient in SIVEXTRO is tedizolid phosphate. One supplier is listed for this compound. Additional details are available on the tedizolid phosphate profile page.
Generic Entry Opportunity Date for 205436
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Suppliers and Packaging for NDA: 205436
Profile for product number 001
|Approval Date:||Jun 20, 2014||TE:||RLD:||Yes|
|Regulatory Exclusivity Expiration:||Jun 20, 2024|
|Regulatory Exclusivity Use:||GENERATING ANTIBIOTIC INCENTIVES NOW|
|Regulatory Exclusivity Expiration:||Jun 20, 2019|
|Regulatory Exclusivity Use:||NEW CHEMICAL ENTITY|
|Patent:||➤ Try a Free Trial||Patent Expiration:||Feb 23, 2028||Product Flag?||Y||Substance Flag?||Y||Delist Request?|
|Patented Use:||METHOD OF TREATING BACTERIAL INFECTIONS|
Complete Access Available with Subscription